TY - JOUR
T1 - Coumadin-induced hepatitis
AU - Leikin, Anna
AU - Merei, Monir
AU - Dahan, Eyal
AU - Blum, Arnon
PY - 2005/2
Y1 - 2005/2
N2 - The diagnosis of "coumadin-induced hepatitis" is compatible with the time relationship between the start of the drug and the onset of hepatopathy, the rapid improvement following discontinuation of the drug, recurrence of liver dysfunction after re-exposure to the drug and liver histology. Although liver damage induced by coumadin derivatives is rare, it is important to be aware of the hepatotoxic potential of these drugs, which, in most cases, mimic the clinical presentation of viral hepatitis.
AB - The diagnosis of "coumadin-induced hepatitis" is compatible with the time relationship between the start of the drug and the onset of hepatopathy, the rapid improvement following discontinuation of the drug, recurrence of liver dysfunction after re-exposure to the drug and liver histology. Although liver damage induced by coumadin derivatives is rare, it is important to be aware of the hepatotoxic potential of these drugs, which, in most cases, mimic the clinical presentation of viral hepatitis.
KW - Coumadin
KW - Liver damage
UR - http://www.scopus.com/inward/record.url?scp=14144251491&partnerID=8YFLogxK
U2 - 10.1016/j.ejim.2004.08.011
DO - 10.1016/j.ejim.2004.08.011
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:14144251491
SN - 0953-6205
VL - 16
SP - 61
EP - 62
JO - European Journal of Internal Medicine
JF - European Journal of Internal Medicine
IS - 1
ER -
